Increased Lyso-Gb1 Levels in an Obese Splenectomized Gaucher Disease Type 1 Patient Treated with Eliglustat: Unacknowledged Poor Compliance or Underlying Factors.
Saved in:
| Title: | Increased Lyso-Gb1 Levels in an Obese Splenectomized Gaucher Disease Type 1 Patient Treated with Eliglustat: Unacknowledged Poor Compliance or Underlying Factors. |
|---|---|
| Authors: | Maines E; Division of Pediatrics, S. Chiara General Hospital, APSS Trento, 38122 Trento, Italy., Franceschi R; Division of Pediatrics, S. Chiara General Hospital, APSS Trento, 38122 Trento, Italy., Luppi G; Division of Radiology, S. Chiara General Hospital, APSS Trento, 38122 Trento, Italy., Marchi G; Department of Medicine, University of Verona, 37129 Verona, Italy., Piccoli G; CIBIO, Department of Cellular, Computational and Integrative Biology, University of Trento, 37129 Trento, Italy., Vitturi N; Division of Metabolic Diseases, Department of Medicine, Padova University Hospital, 35128 Padova, Italy., Soffiati M; Division of Pediatrics, S. Chiara General Hospital, APSS Trento, 38122 Trento, Italy., Campomori A; Hospital Pharmacy Unit, S. Chiara General Hospital, APSS Trento, 38122 Trento, Italy., Urru SAM; Hospital Pharmacy Unit, S. Chiara General Hospital, APSS Trento, 38122 Trento, Italy. |
| Source: | Metabolites [Metabolites] 2025 Jun 23; Vol. 15 (7). Date of Electronic Publication: 2025 Jun 23. |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101578790 Publication Model: Electronic Cited Medium: Print ISSN: 2218-1989 (Print) Linking ISSN: 22181989 NLM ISO Abbreviation: Metabolites Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
